Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2020-09-30 04:26 2020-09-25 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner SELL $33.98 724 $24,599 20,000
2020-09-29 01:13 2020-09-25 NVCR NovoCure Ltd Weinberg Uri Officer OPT+S $103.35 15,250 $1,576,088 27,597
2020-09-29 04:27 2020-09-25 TFX TELEFLEX INC Klasko Stephen K. M.D. Director OPT+S $326.15 200 $65,230 1,121
2020-09-29 00:35 2020-09-25 DXCM DEXCOM INC Pacelli Steven Robert Officer SELL $400.07 2,000 $800,137 65,218
2020-09-29 00:35 2020-09-24 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer SELL $380.95 1,530 $582,861 0
2020-09-25 23:43 2020-09-22 ATAO Premier Air Charter Holdings Inc. EROP Capital LLC SELL $0.25 13,610 $3,403 50,026,212
2020-09-26 00:00 2020-09-24 XAIR Beyond Air, Inc. BECK DOUGLAS Officer BUY $4.88 3,000 $14,640 64,710
2020-09-25 18:11 2020-09-23 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $6.14 300 $1,842 14,063,989
2020-09-26 04:58 2020-09-23 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner SELL $33.73 9,276 $312,852 20,724
2020-09-24 23:17 2020-09-22 INSP Inspire Medical Systems, Inc. Buchholz Richard Officer SELL $126.09 6,000 $756,556 66,384
2020-09-24 23:30 2020-09-23 DXCM DEXCOM INC Pacelli Steven Robert Officer SELL $395.11 1,079 $426,324 67,218
2020-09-24 03:37 2020-09-22 PDEX PRO DEX INC Van Kirk Richard Lee Jr Director, Officer SELL $27.49 10,265 $282,152 48,910
2020-09-23 22:36 2020-09-22 INFU InfuSystem Holdings, Inc Lachance Carrie Officer BUY $13.20 2,000 $26,400 79,793
2020-09-23 22:31 2020-09-21 INFU InfuSystem Holdings, Inc Steele Barry G Officer BUY $13.07 2,000 $26,140 16,981
2020-09-22 23:08 2020-09-18 SIBN SI-BONE, Inc. Pisetsky Michael A Officer OPT+S $25.00 3,000 $75,000 49,252
2020-09-22 18:39 2020-09-21 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $6.49 500 $3,245 14,063,689
2020-09-21 23:34 2020-09-17 IART INTEGRA LIFESCIENCES HOLDINGS CORP Tru St Partnership, L.P. 10% owner SELL $46.97 200,000 $9,394,000 10,091,205
2020-09-21 23:16 2020-09-18 NVCR NovoCure Ltd GROENHUYSEN WILHELMUS CM Officer OPT+S $109.21 8,262 $902,294 142,607
2020-09-19 00:20 2020-09-15 ATAO Premier Air Charter Holdings Inc. EROP Capital LLC SELL $0.34 21,700 $7,484 50,039,822
2020-09-18 23:37 2020-09-16 NVCR NovoCure Ltd GROENHUYSEN WILHELMUS CM Officer OPT+S $107.81 34,512 $3,720,570 142,607
2020-09-18 22:58 2020-09-16 SIBN SI-BONE, Inc. RECUPERO ANTHONY J Officer OPT+S $24.05 3,000 $72,160 71,079
2020-09-18 23:57 2020-09-16 DXCM DEXCOM INC AUGUSTINOS NICHOLAS Director SELL $399.78 1,875 $749,596 13,842
2020-09-18 00:53 2020-09-16 CRY Artivion Inc. Davis John E Officer BUY $16.65 10,000 $166,459 70,451
2020-09-17 23:32 2020-09-15 NVCR NovoCure Ltd Danziger Asaf Director, Officer OPT+S $99.00 103,000 $10,197,000 197,632
2020-09-18 00:58 2020-09-16 TNDM TANDEM DIABETES CARE INC HANSEN BRIAN B Officer OPT+S $113.00 10,525 $1,189,328 4,665
2020-09-18 00:45 2020-09-15 TNDM TANDEM DIABETES CARE INC Sheridan John F Officer OPT+S $110.02 10,000 $1,100,180 3,756
2020-09-18 00:50 2020-09-16 CRY Artivion Inc. Bullock James Director BUY $16.63 10,000 $166,273 34,023
2020-09-17 00:47 2020-09-14 INSP Inspire Medical Systems, Inc. Tansey Casey M Director SELL $129.27 12,000 $1,551,211 18,830
2020-09-16 23:00 2020-09-15 PDEX PRO DEX INC Charlton Alisha Officer SELL $30.18 1,500 $45,268 5,752
2020-09-17 00:01 2020-09-15 RMD RESMED INC Douglas Robert Andrew Officer SELL $175.49 1,147 $201,287 183,438
2020-09-17 01:35 2020-09-15 RMD RESMED INC Sandercock Brett Officer SELL $175.49 2,500 $438,725 86,775
2020-09-16 23:12 2020-09-14 ATRC AtriCure, Inc. GROVES REGINA E Director SELL $41.83 6,313 $264,073 21,809
2020-09-17 02:49 2020-09-14 PEN Penumbra Inc O'Rourke Bridget Director SELL $200.97 65 $13,063 3,258
2020-09-17 00:24 2020-09-14 NVCR NovoCure Ltd GROENHUYSEN WILHELMUS CM Officer OPT+S $101.53 75,868 $7,703,227 142,607
2020-09-17 02:15 2020-09-14 RCEL AVITA Medical, Inc. PERRY MICHAEL S Director, Officer SELL $27.19 47,861 $1,301,254 425,087
2020-09-17 00:27 2020-09-14 NVCR NovoCure Ltd LEUNG GABRIEL Director OPT+S $97.44 19,565 $1,906,500 72,045
2020-09-16 23:14 2020-09-14 SIBN SI-BONE, Inc. FRANCIS LAURA Officer OPT+S $23.02 2,547 $58,628 135,261
2020-09-17 02:36 2020-09-15 DXCM DEXCOM INC ALTMAN STEVEN R Director SELL $393.92 30,000 $11,817,600 12,980
2020-09-16 23:44 2020-09-14 DXCM DEXCOM INC FOLETTA MARK G Director SELL $394.14 1,000 $394,136 15,202
2020-09-16 23:44 2020-09-15 DXCM DEXCOM INC Balo Andrew K Officer SELL $397.35 5,256 $2,088,490 35,567
2020-09-16 03:52 2020-09-11 PEN Penumbra Inc Elsesser Adam Director, Officer SELL $200.73 8,000 $1,605,862 981,582
2020-09-15 23:07 2020-09-14 BAX BAXTER INTERNATIONAL INC FORSYTH JOHN D Director OPT+S $83.59 310 $25,913 33,969
2020-09-14 23:04 2020-09-11 BSX BOSTON SCIENTIFIC CORP Fitzgerald Joseph Michael Officer OPT+S $40.76 77,640 $3,164,653 221,048
2020-09-11 23:19 2020-09-09 NVCR NovoCure Ltd Shah Pritesh Officer SELL $85.41 28,321 $2,418,880 70,465
2020-09-11 23:13 2020-09-02 NVCR NovoCure Ltd Shah Pritesh Officer SELL $85.01 4,200 $357,054 98,786
2020-09-11 23:15 2020-09-09 INSP Inspire Medical Systems, Inc. Ban Randy Officer OPT+S $117.54 30,000 $3,526,269 189
2020-09-12 02:59 2020-09-10 RCEL AVITA Medical, Inc. PERRY MICHAEL S Director, Officer SELL $26.08 27,128 $707,582 404,444
2020-09-12 00:00 2020-09-10 UFPT UFP TECHNOLOGIES INC SHAW DANIEL J Officer SELL $40.80 7,759 $316,567 12,274
2020-09-11 23:15 2020-09-09 NVCR NovoCure Ltd LEUNG GABRIEL Director OPT+S $87.80 19,114 $1,678,293 72,045
2020-09-12 01:59 2020-09-09 DXCM DEXCOM INC Sylvain Jereme M Officer SELL $398.30 289 $115,109 12,532
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.